Ginwa Enterprise Group Inc Market Cap ($217.39 Million)
Market Cap & Net Worth: Ginwa Enterprise Group Inc (600080)
Ginwa Enterprise Group Inc market cap. Ginwa Enterprise Group Inc (SHG:600080) has a market capitalization of $217.39 Million (CN¥1.49 Billion) as of November 8, 2026. Listed on the SHG stock exchange, this China-based company holds position #15983 globally and #4596 in its home market, demonstrating a 0.25% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ginwa Enterprise Group Inc's stock price CN¥3.98 by its total outstanding shares 373270285 (373.27 Million). Also see Ginwa Enterprise Group Inc operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Ginwa Enterprise Group Inc Market Cap History (2015–2026)
Ginwa Enterprise Group Inc market cap history from 2015 to 2026. Data shows change from $759.19 Million to $217.39 Million (-7.75% CAGR). Check current stock price of Ginwa Enterprise Group Inc for real-time trading data and today's change.
Ginwa Enterprise Group Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ginwa Enterprise Group Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 600080 shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.76x
Ginwa Enterprise Group Inc's market cap is 0.76 times its annual revenue
Latest Price to Earnings (P/E) Ratio
26.44x
Ginwa Enterprise Group Inc's market cap is 26.44 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $665.41 Million | $666.65 Million | $27.30 Million | 1.00x | 24.37x |
| 2017 | $434.01 Million | $757.18 Million | $53.46 Million | 0.57x | 8.12x |
| 2018 | $381.57 Million | $745.16 Million | $38.32 Million | 0.51x | 9.96x |
| 2019 | $323.33 Million | $754.54 Million | $25.90 Million | 0.43x | 12.48x |
| 2020 | $301.46 Million | $668.18 Million | $37.74 Million | 0.45x | 7.99x |
| 2021 | $465.92 Million | $534.04 Million | -$18.16 Million | 0.87x | N/A |
| 2022 | $426.59 Million | $579.37 Million | $33.46 Million | 0.74x | 12.75x |
| 2023 | $406.93 Million | $565.40 Million | -$42.89 Million | 0.72x | N/A |
| 2024 | $426.59 Million | $585.46 Million | $74.61 Million | 0.73x | 5.72x |
| 2025 | $411.84 Million | $544.04 Million | $15.58 Million | 0.76x | 26.44x |
Competitor Companies of 600080 by Market Capitalization
Companies near Ginwa Enterprise Group Inc in the global market cap rankings as of November 8, 2026. Also see how large is Ginwa Enterprise Group Inc's balance sheet for a full breakdown of the balance sheet.
Key companies related to Ginwa Enterprise Group Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #530 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #567 globally with a market cap of $47.07 Billion USD ( CN¥321.69 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #609 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #530 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.61 |
| #567 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $47.07 Billion | CN¥50.43 |
| #609 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.80 |
Market Capitalization of Ginwa Enterprise Group Inc (2015–2026)
Market capitalization of Ginwa Enterprise Group Inc from 2015 to today. Between 2015 and today, Ginwa Enterprise Group Inc's market cap moved from $759.19 Million to $ 217.39 Million, with a yearly change of -7.75%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥217.39 Million | -47.21% |
| 2025 | CN¥411.84 Million | -3.46% |
| 2024 | CN¥426.59 Million | +4.83% |
| 2023 | CN¥406.93 Million | -4.61% |
| 2022 | CN¥426.59 Million | -8.44% |
| 2021 | CN¥465.92 Million | +54.55% |
| 2020 | CN¥301.46 Million | -6.76% |
| 2019 | CN¥323.33 Million | -15.26% |
| 2018 | CN¥381.57 Million | -12.08% |
| 2017 | CN¥434.01 Million | -34.78% |
| 2016 | CN¥665.41 Million | -12.35% |
| 2015 | CN¥759.19 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 8th, 2026 the market cap of Ginwa Enterprise Group Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $217.39 Million USD |
| MoneyControl | $217.39 Million USD |
| MarketWatch | $217.39 Million USD |
| marketcap.company | $217.39 Million USD |
| Reuters | $217.39 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Ginwa Enterprise Group Inc
Ginwa Enterprise (Group) Inc. researches, develops, produces, markets, and sells traditional Chinese medicines, biological drugs, and chemical drugs primarily in China. The company offers a range of orthopaedics, immunity, children, and general medicines in various dosage forms, including tablets, capsules, granules, powders, mixtures, oral solutions, syrups, and external solutions. It is also in… Read more